Increased colorectal cancer screenings among 45-49 year-olds are linked to more early-stage diagnoses, according to new American Cancer Society research. Screenings in this age group rose significantly from 2019 to 2023, following a 2018 recommendation to lower the screening age from 50 to 45. Early detection significantly improves curability, exceeding 90% in the earliest stages. However, disparities in screening rates remain based on education and insurance status, raising concerns about equitable access. Recent concerns have emerged regarding potential changes to the U.S. Preventive Services Task Force, which could negatively impact preventative care.

Prepared by Olivia Bennett and reviewed by editorial team.